FDA Inspection
Miracles in SightMiracles in Sight – FDA Inspection, Jan 30, 2020
Record Details
This FDA Inspection record concerns Miracles in Sight, with an inspection on January 30, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Miracles in Sight
- Inspection Date
- January 30, 2020
- Product Type
- Biologics
View Company Profile
ID · 6da13c22-297b-4033-b6a7-8008e24680c8
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1118762
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Miracles in Sight
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 10, 2025 | Not classified | Atlanta District Office | |
| September 18, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 11, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 23, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 26, 2014 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Miracles in Sight
- FDA Inspection 1264026 - 2025-03-10
- FDA Inspection 1218383 - 2023-09-18
- FDA Inspection 1023209 - 2017-08-11
- FDA Inspection 943193 - 2015-09-23
- FDA Inspection 868748 - 2014-02-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.